Comparison of the efficacy of prophylaxis with Pregabalin and Sodium Valproate on intensity and frequency of migraine type headache in Iranian patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Pregabalin (Primary) ; Sodium valproate
- Indications Migraine
- Focus Therapeutic Use
- 10 Mar 2014 Status changed from recruiting to active, no longer recruiting, as per Iranian Registry of Clinical Trials record.
- 13 May 2013 Recruitment expected to complete on 20 Jan 2014.
- 13 May 2013 New trial record